Cargando…
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838164/ https://www.ncbi.nlm.nih.gov/pubmed/31700121 http://dx.doi.org/10.1038/s41598-019-53130-4 |
| _version_ | 1783467174043582464 |
|---|---|
| author | Zhu, Guoyun Foletti, Davide Liu, Xiaohui Ding, Sheng Melton Witt, Jody Hasa-Moreno, Adela Rickert, Mathias Holz, Charles Aschenbrenner, Laura Yang, Amy H. Kraynov, Eugenia Evering, Winston Obert, Leslie Lee, Chenyu Sai, Tao Mistry, Tina Lindquist, Kevin C. Van Blarcom, Thomas Strop, Pavel Chaparro-Riggers, Javier Liu, Shu-Hui |
| author_facet | Zhu, Guoyun Foletti, Davide Liu, Xiaohui Ding, Sheng Melton Witt, Jody Hasa-Moreno, Adela Rickert, Mathias Holz, Charles Aschenbrenner, Laura Yang, Amy H. Kraynov, Eugenia Evering, Winston Obert, Leslie Lee, Chenyu Sai, Tao Mistry, Tina Lindquist, Kevin C. Van Blarcom, Thomas Strop, Pavel Chaparro-Riggers, Javier Liu, Shu-Hui |
| author_sort | Zhu, Guoyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6838164 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68381642019-11-14 Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer Zhu, Guoyun Foletti, Davide Liu, Xiaohui Ding, Sheng Melton Witt, Jody Hasa-Moreno, Adela Rickert, Mathias Holz, Charles Aschenbrenner, Laura Yang, Amy H. Kraynov, Eugenia Evering, Winston Obert, Leslie Lee, Chenyu Sai, Tao Mistry, Tina Lindquist, Kevin C. Van Blarcom, Thomas Strop, Pavel Chaparro-Riggers, Javier Liu, Shu-Hui Sci Rep Author Correction Nature Publishing Group UK 2019-11-08 /pmc/articles/PMC6838164/ /pubmed/31700121 http://dx.doi.org/10.1038/s41598-019-53130-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Zhu, Guoyun Foletti, Davide Liu, Xiaohui Ding, Sheng Melton Witt, Jody Hasa-Moreno, Adela Rickert, Mathias Holz, Charles Aschenbrenner, Laura Yang, Amy H. Kraynov, Eugenia Evering, Winston Obert, Leslie Lee, Chenyu Sai, Tao Mistry, Tina Lindquist, Kevin C. Van Blarcom, Thomas Strop, Pavel Chaparro-Riggers, Javier Liu, Shu-Hui Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title | Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title_full | Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title_fullStr | Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title_full_unstemmed | Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title_short | Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer |
| title_sort | author correction: targeting cldn18.2 by cd3 bispecific and adc modalities for the treatments of gastric and pancreatic cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838164/ https://www.ncbi.nlm.nih.gov/pubmed/31700121 http://dx.doi.org/10.1038/s41598-019-53130-4 |
| work_keys_str_mv | AT zhuguoyun authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT folettidavide authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT liuxiaohui authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT dingsheng authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT meltonwittjody authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT hasamorenoadela authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT rickertmathias authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT holzcharles authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT aschenbrennerlaura authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT yangamyh authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT kraynoveugenia authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT everingwinston authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT obertleslie authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT leechenyu authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT saitao authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT mistrytina authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT lindquistkevinc authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT vanblarcomthomas authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT stroppavel authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT chaparroriggersjavier authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer AT liushuhui authorcorrectiontargetingcldn182bycd3bispecificandadcmodalitiesforthetreatmentsofgastricandpancreaticcancer |